Selected article for: "acute sars cov respiratory syndrome coronavirus and adaptive immunity"
Author: Fernández-Lázaro, Diego; Fernandez-Lazaro, Cesar I.; Mielgo-Ayuso, Juan; Adams, David P.; García Hernández, Juan Luis; González-Bernal, Jerónimo; González-Gross, Marcela
Title: Glycophosphopeptical AM3 Food Supplement: A Potential Adjuvant in the Treatment and Vaccination of SARS-CoV-2
  • Cord-id: lykurmu6
  • Document date: 2021_6_17
    • ID: lykurmu6
    Snippet: The world is currently experiencing the coronavirus disease 2019 (COVID-19) pandemic caused by Severe Acute Respiratory Syndrome-2 (SARS-CoV-2). Its global spread has resulted in millions of confirmed infections and deaths. While the global pandemic continues to grow, the availability of drugs to treat COVID-19 infections remains limited to supportive treatments. Moreover, the current speed of vaccination campaigns in many countries has been slow. Natural substrates with biological immunomodulat
    Document: The world is currently experiencing the coronavirus disease 2019 (COVID-19) pandemic caused by Severe Acute Respiratory Syndrome-2 (SARS-CoV-2). Its global spread has resulted in millions of confirmed infections and deaths. While the global pandemic continues to grow, the availability of drugs to treat COVID-19 infections remains limited to supportive treatments. Moreover, the current speed of vaccination campaigns in many countries has been slow. Natural substrates with biological immunomodulatory activity, such as glucans, may represent an adjuvant therapeutic agent to treat SARS-CoV-2. AM3, a natural glycophosphopeptical, has previously been shown to effectively slow, with no side effects, the progression of infectious respiratory diseases by regulating effects on innate and adaptive immunity in experimental models. No clinical studies, however, exist on the use of AM3 in SARS-CoV-2 infected patients. This review aims to summarize the beneficial effects of AM3 on respiratory diseases, the inflammatory response, modulation of immune response, and attenuation of muscle. It will also discuss its potential effects as an immune system adjuvant for the treatment of COVID-19 infections and adjuvant for SARS-CoV-2 vaccination.

    Search related documents:
    Co phrase search for related documents
    • action non and acute respiratory: 1, 2, 3, 4, 5, 6
    • action non and adaptive immunity: 1
    • activation cell adhesion and acute phase: 1
    • activation cell adhesion and acute respiratory: 1, 2, 3, 4, 5, 6
    • activation cell adhesion and acute respiratory distress syndrome: 1
    • activator signal transducer and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • activator signal transducer and acute respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • activator signal transducer and adaptive immune system: 1
    • activator signal transducer and adaptive immunity: 1, 2
    • activator signal transducer and adaptive immunity innate: 1
    • activator signal transducer and adaptive innate: 1, 2, 3, 4
    • activator signal transducer and adaptive innate immunity: 1
    • active ingredient and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • active ingredient and acute respiratory distress syndrome: 1
    • acute phase and adaptive immune system: 1, 2, 3, 4
    • acute phase and adaptive immunity: 1, 2, 3, 4, 5, 6, 7
    • acute phase and adaptive immunity innate: 1, 2, 3
    • acute phase and adaptive innate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • acute phase and adaptive innate immunity: 1, 2, 3